193 related articles for article (PubMed ID: 16230887)
41. [2 promising substances for diastolic heart failure].
Einecke D
MMW Fortschr Med; 2012 Sep; 154(15):22. PubMed ID: 22997932
[No Abstract] [Full Text] [Related]
42. Neurohumoral blockade in CHF management.
Willenbrock R; Philipp S; Mitrovic V; Dietz R
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1 Suppl 1():24-30. PubMed ID: 11967792
[TBL] [Abstract][Full Text] [Related]
43. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
Zeller A; Battegay E
Praxis (Bern 1994); 2005 Apr; 94(15):581-94. PubMed ID: 15884724
[TBL] [Abstract][Full Text] [Related]
44. Valsartan in chronic heart failure.
Campbell DJ
N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951863
[No Abstract] [Full Text] [Related]
45. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
46. Are angiotensin II receptor blockers indicated in chronic heart failure?
Komajda M
Heart; 2002 Jan; 87(1):1-2. PubMed ID: 11751648
[No Abstract] [Full Text] [Related]
47. Angiotensin II type 1 receptor blockers and congestive heart failure.
Auer JW; Berent R; Eber B
Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
[No Abstract] [Full Text] [Related]
48. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
Cohn JN; Tognoni G;
N Engl J Med; 2001 Dec; 345(23):1667-75. PubMed ID: 11759645
[TBL] [Abstract][Full Text] [Related]
49. Lessons learned from the valsartan- heart failure trial (Val-HeFT): angiotensin receptor blockers in heart failure.
Cohn JN
Am J Cardiol; 2002 Nov; 90(9):992-3. PubMed ID: 12398968
[No Abstract] [Full Text] [Related]
50. Addition of losartan to angiotensin-converting enzyme inhibitors improves insulin resistance in patients with chronic heart failure treated without β-blockers.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Kaetsu Y; Mizuta E; Sugihara S; Ishida K; Yanagihara K; Hisatome I; Shigemasa C
Circ J; 2010 Nov; 74(11):2346-52. PubMed ID: 20827028
[TBL] [Abstract][Full Text] [Related]
51. Valsartan in chronic heart failure.
Cayley WE
N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951861
[No Abstract] [Full Text] [Related]
52. Angiotensin II receptor blockers for the treatment of hypertension.
See S
Expert Opin Pharmacother; 2001 Nov; 2(11):1795-804. PubMed ID: 11825317
[TBL] [Abstract][Full Text] [Related]
53. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
54. The renin-angiotensin system: the role of inhibitors, blockers, and genetic polymorphisms in the treatment and prevention of heart failure.
Hebert PR; Foody JM; Hennekens CH
Curr Vasc Pharmacol; 2003 Mar; 1(1):33-9. PubMed ID: 15320851
[TBL] [Abstract][Full Text] [Related]
55. Cardiac protection: evolving role of angiotensin receptor blockers.
Califf RM; Cohn JN
Am Heart J; 2000 Jan; 139(1 Pt 2):S15-22. PubMed ID: 10618583
[TBL] [Abstract][Full Text] [Related]
56. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
[TBL] [Abstract][Full Text] [Related]
57. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure.
Desai RJ; Ashton CM; Deswal A; Morgan RO; Mehta HB; Chen H; Aparasu RR; Johnson ML
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):233-40. PubMed ID: 21786364
[TBL] [Abstract][Full Text] [Related]
58. Valsartan in the treatment of heart attack survivors.
Jugdutt BI
Vasc Health Risk Manag; 2006; 2(2):125-38. PubMed ID: 17319456
[TBL] [Abstract][Full Text] [Related]
59. The addition of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors--what has time told us?
Fabi MR; Teerlink JR
Curr Heart Fail Rep; 2005 Aug; 2(2):59-64. PubMed ID: 16036052
[TBL] [Abstract][Full Text] [Related]
60. Renin-angiotensin system inhibition: how much is too much of a good thing?
Campbell DJ
Intern Med J; 2002 Dec; 32(12):616-20. PubMed ID: 12512757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
